Latest news
Lexeo Therapeutics, Inc. (NASDAQ:LXEO) Receives Average Rating of "Buy" from Brokerages - MarketBeatMarketBeat · Mon, 10 Aug 2026 08:33:05 GMTLexeo Therapeutics (LXEO) Projected to Release Earnings on Thursday - MarketBeatMarketBeat · Thu, 06 Aug 2026 08:12:14 GMTLexeo Therapeutics, Inc. $LXEO Shares Sold by Janus Henderson Group PLC - MarketBeatMarketBeat · Mon, 03 Aug 2026 10:10:21 GMT